Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GE GE Aerospace	$236.38 -0.1%	$216.42	$150.20 ▼ $257.47	$252.07B	1.38	5.42 million shs	4.40 million shs
JNJ Johnson & Johnson	$155.24 -1.2%	$153.84	$140.68 ▼ $169.99	$373.52B	0.42	7.96 million shs	7.02 million shs
KO Coca-Cola	$70.51 -0.7%	$71.56	$60.62 ▼ $74.38	$303.50B	0.46	15.88 million shs	15.04 million shs
PFE Pfizer	$24.40 -0.6%	$23.06	$20.92 ▼ $31.54	$138.71B	0.57	41.18 million shs	35.08 million shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GE GE Aerospace	0.00%	-7.68%	+1.82%	+16.73%	+51.44%
JNJ Johnson & Johnson	0.00%	+1.21%	+3.66%	-3.71%	+7.81%
KO Coca-Cola	0.00%	-0.60%	-1.48%	+1.14%	+13.42%
PFE Pfizer	0.00%	+4.93%	+7.39%	-5.97%	-10.97%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GE GE Aerospace	4.6632 of 5 stars	2.5	5.0	1.7	2.8	3.9	2.5	1.9
JNJ Johnson & Johnson	4.9318 of 5 stars	3.3	5.0	4.2	3.9	3.0	1.7	1.9
KO Coca-Cola	4.4006 of 5 stars	2.5	5.0	3.3	0.8	2.9	2.5	1.3
PFE Pfizer	4.9768 of 5 stars	3.3	4.0	4.2	4.3	2.8	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GE GE Aerospace	2.92	Moderate Buy	$221.15	-6.44% Downside
JNJ Johnson & Johnson	2.55	Moderate Buy	$170.88	10.07% Upside
KO Coca-Cola	3.05	Buy	$76.00	7.78% Upside
PFE Pfizer	2.53	Moderate Buy	$29.17	19.55% Upside

Current Analyst Ratings Breakdown

Latest GE, JNJ, PFE, and KO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/9/2025	KO Coca-Cola	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$81.00
6/5/2025	JNJ Johnson & Johnson	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$181.00
6/3/2025	GE GE Aerospace	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$220.00 ➝ $275.00
5/19/2025	GE GE Aerospace	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
5/13/2025	JNJ Johnson & Johnson	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/13/2025	JNJ Johnson & Johnson	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform	$169.00 ➝ $153.00
4/30/2025	KO Coca-Cola	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$73.00 ➝ $76.00
4/30/2025	KO Coca-Cola	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$84.00 ➝ $86.00
4/30/2025	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$24.00 ➝ $25.00
4/24/2025	GE GE Aerospace	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$212.00 ➝ $222.00
4/24/2025	JNJ Johnson & Johnson	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GE GE Aerospace	$39.68B	6.35	$6.56 per share	36.03	$18.23 per share	12.97
JNJ Johnson & Johnson	$89.33B	4.18	$12.76 per share	12.17	$29.69 per share	5.23
KO Coca-Cola	$46.89B	6.47	$3.16 per share	22.29	$6.12 per share	11.52
PFE Pfizer	$62.46B	2.22	$3.82 per share	6.38	$15.81 per share	1.54

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GE GE Aerospace	$6.56B	$6.43	39.46	36.59	2.59	14.31%	22.19%	3.66%	7/22/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$8.99	23.34	14.02	2.56	18.20%	34.24%	13.63%	7/16/2025 (Estimated)
KO Coca-Cola	$10.63B	$2.50	28.55	22.10	3.79	22.59%	45.37%	12.24%	7/22/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	17.30	8.05	0.64	12.62%	19.47%	8.09%	7/29/2025 (Estimated)

Latest GE, JNJ, PFE, and KO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/29/2025	Q1 2025	KO Coca-Cola	$0.71	$0.73	+$0.02	$0.77	$11.23 billion	$11.13 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/22/2025	Q1 2025	GE GE Aerospace	$1.29	$1.49	+$0.20	$1.83	$9.06 billion	$9.94 billion
4/15/2025	Q1 2025	JNJ Johnson & Johnson	$2.59	$2.77	+$0.18	$4.54	$21.65 billion	$21.89 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GE GE Aerospace	$1.44	0.61%	N/A	22.40%	2 Years
JNJ Johnson & Johnson	$5.20	3.35%	N/A	57.84%	64 Years
KO Coca-Cola	$2.04	2.89%	N/A	81.60%	64 Years
PFE Pfizer	$1.72	7.05%	N/A	124.64%	16 Years

Latest GE, JNJ, PFE, and KO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	KO Coca-Cola	quarterly	$0.51	2.86%	6/13/2025	6/13/2025	7/1/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025
4/15/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.37%	5/27/2025	5/27/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GE GE Aerospace	0.88	1.09	0.81
JNJ Johnson & Johnson	0.43	1.11	0.86
KO Coca-Cola	1.61	1.03	0.84
PFE Pfizer	0.63	1.00	0.73

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GE GE Aerospace	74.77%
JNJ Johnson & Johnson	69.55%
KO Coca-Cola	70.26%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
GE GE Aerospace	0.21%
JNJ Johnson & Johnson	0.16%
KO Coca-Cola	0.97%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GE GE Aerospace	172,000	1.07 billion	1.07 billion	Optionable
JNJ Johnson & Johnson	152,700	2.41 billion	2.40 billion	Optionable
KO Coca-Cola	82,500	4.30 billion	4.27 billion	Optionable
PFE Pfizer	83,000	5.69 billion	5.66 billion	Optionable

GE, JNJ, PFE, and KO Headlines

Recent News About These Companies

Pfizer (PFE) Experiences Mixed Options Sentiment Amidst Price Drop | PFE Stock News

June 16 at 2:17 PM | gurufocus.com

PFE or LLY: Which Is the Better Value Stock Right Now?

June 16 at 12:41 PM | zacks.com

4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil

June 16 at 10:31 AM | zacks.com

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

June 16 at 10:11 AM | zacks.com

Signature Wealth Management Group Purchases 20,873 Shares of Pfizer Inc. (NYSE:PFE)

June 16 at 7:52 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Shares Bought by Stockman Wealth Management Inc.

June 16 at 7:51 AM | marketbeat.com

Claris Advisors LLC MO Purchases 14,647 Shares of Pfizer Inc. (NYSE:PFE)

June 16 at 7:51 AM | marketbeat.com

QRG Capital Management Inc. Has $17.74 Million Position in Pfizer Inc. (NYSE:PFE)

June 16 at 7:44 AM | marketbeat.com

Hanson & Doremus Investment Management Raises Position in Pfizer Inc. (NYSE:PFE)

June 16 at 6:08 AM | marketbeat.com

Goldman Sachs Maintains a Hold Rating on Pfizer (NYSE:PFE), Retains $27 PT

June 15 at 4:48 PM | msn.com

Pfizer Inc. (NYSE:PFE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

June 15 at 4:48 PM | finance.yahoo.com

Trust Co. of Toledo NA OH Grows Holdings in Pfizer Inc. (NYSE:PFE)

June 15 at 9:03 AM | marketbeat.com

Mn Services Vermogensbeheer B.V. Has $52.41 Million Position in Pfizer Inc. (NYSE:PFE)

June 15 at 9:02 AM | marketbeat.com

Exchange Traded Concepts LLC Purchases 516,582 Shares of Pfizer Inc. (NYSE:PFE)

June 15 at 7:59 AM | marketbeat.com

Factory Mutual Insurance Co. Cuts Position in Pfizer Inc. (NYSE:PFE)

June 15 at 7:51 AM | marketbeat.com

Atlas Private Wealth Advisors Trims Holdings in Pfizer Inc. (NYSE:PFE)

June 15 at 7:44 AM | marketbeat.com

Pfizer Inc. (NYSE:PFE) Position Increased by BayBridge Capital Group LLC

June 15 at 7:43 AM | marketbeat.com

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $52.55 Million Stock Position in Pfizer Inc. (NYSE:PFE)

June 15 at 7:21 AM | marketbeat.com

Sound Income Strategies LLC Has $20.04 Million Stake in Pfizer Inc. (NYSE:PFE)

June 15 at 7:21 AM | marketbeat.com

Foster Victor Wealth Advisors LLC Buys 34,440 Shares of Pfizer Inc. (NYSE:PFE)

June 15 at 7:05 AM | marketbeat.com

Wilsey Asset Management Inc. Acquires 58,372 Shares of Pfizer Inc. (NYSE:PFE)

June 15 at 6:16 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook
By Leo Miller | May 27, 2025
View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and Outlook
Palantir Scores First $1 Billion Contract; Is It Priced In?
By Chris Markoch | May 27, 2025
View Palantir Scores First $1 Billion Contract; Is It Priced In?

GE, JNJ, PFE, and KO Company Descriptions

GE Aerospace NYSE:GE

$236.38 -0.22 (-0.09%)

Closing price 03:59 PM Eastern

Extended Trading

$235.50 -0.88 (-0.37%)

As of 07:59 PM Eastern

GE Aerospace (also known as General Electric) is a company that specializes in providing aerospace products and services. It operates through two reportable segments: Commercial Engines and Services and Defense and Propulsion Technologies. It offers jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. GE demerged into GE Vernova, GE Aerospace, and GE Healthcare.

Johnson & Johnson NYSE:JNJ

$155.24 -1.86 (-1.18%)

Closing price 03:59 PM Eastern

Extended Trading

$155.00 -0.25 (-0.16%)

As of 07:58 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Coca-Cola NYSE:KO

$70.51 -0.51 (-0.72%)

Closing price 03:59 PM Eastern

Extended Trading

$70.58 +0.07 (+0.10%)

As of 07:59 PM Eastern

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Pfizer NYSE:PFE

$24.40 -0.14 (-0.58%)

Closing price 03:59 PM Eastern

Extended Trading

$24.38 -0.02 (-0.07%)

As of 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time